NASDAQ | ETF
The fund invests at least 80% of its total assets in the securities of the underlying index.
The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 5.27% |
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 4.51% |
RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 4.51% |
ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 4.43% |
QGEN | Qiagen NV | Healthcare | Diagnostics & Research | 4.42% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 4.25% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 4.10% |
TECH | Bio-Techne Corp | Healthcare | Biotechnology | 4.04% |
RARE | Ultragenyx | Healthcare | Biotechnology | 4.04% |
CRSP | Crispr Therapeutics AG | Healthcare | Biotechnology | 4.00% |
GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.84% |
BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 3.84% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.77% |
LEGN | Legend Biotech Corp | Healthcare | Biotechnology | 3.56% |
VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 2.81% |
SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 2.64% |
ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 2.55% |
WGS | GeneDx Holdings Corp. | Healthcare | Diagnostics & Research | 2.51% |
1548 | Genscript Biotech Corp | Healthcare | Biotechnology | 2.41% |
TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 2.39% |